ENTR
L&G Energy Transition Commodities UCITS ETF
Investor Moves
News
globenewswire.comEntrada Therapeutics Announces Positive Topline Results from Cohort 1 of Participants with Duchenne Muscular Dystrophy Treated with ENTR-601-44 in Phase 1/2 ELEVATE-44-201 Studyglobenewswire.comMay 7
globenewswire.comEntrada Therapeutics to Announce Topline Results from Cohort 1 of Participants with Duchenne Muscular Dystrophy Treated with ENTR-601-44 in Phase 1/2 ELEVATE-44-201 Study on May 7, 2026globenewswire.comMay 6